1. INTRODUCTION
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Market Segmentation
1.5. Currency
1.6. Assumptions
1.7. Base, and Forecast Years Timeline
1.8. Key Benefits for the stakeholder
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Research Processes
3. EXECUTIVE SUMMARY
3.1. Key Findings
3.2. Analyst View
4. MARKET DYNAMICS
4.1. Market Drivers
4.2. Market Restraints
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
4.5. Analyst View
5. ANIMAL SEDATIVE MARKET BY DRUG CLASS
5.1. Introduction
5.2. Phenothiazines
5.2.1. Market Trends and Opportunities
5.2.2. Growth Prospects
5.3. Benzodiazepines
5.3.1. Market Trends and Opportunities
5.3.2. Growth Prospects
5.4. Alpha-2 adrenergic Receptor Agonists
5.4.1. Market Trends and Opportunities
5.4.2. Growth Prospects
5.5. Butyrophenones
5.5.1. Market Trends and Opportunities
5.5.2. Growth Prospects
5.6. Others
5.6.1. Market Trends and Opportunities
5.6.2. Growth Prospects
6. ANIMAL SEDATIVE MARKET BY ANIMAL TYPE
6.1. Introduction
6.2. Small
6.2.1. Market Trends and Opportunities
6.2.2. Growth Prospects
6.3. Large
6.3.1. Market Trends and Opportunities
6.3.2. Growth Prospects
7. ANIMAL SEDATIVE MARKET BY ROUTE OF ADMINISTRATION
7.1. Introduction
7.2. Parenteral
7.2.1. Market Trends and Opportunities
7.2.2. Growth Prospects
7.3. Oral
7.3.1. Market Trends and Opportunities
7.3.2. Growth Prospects
8. ANIMAL SEDATIVE MARKET BY APPLICATION
8.1. Introduction
8.2. Surgical
8.2.1. Market Trends and Opportunities
8.2.2. Growth Prospects
8.3. Diagnosis
8.3.1. Market Trends and Opportunities
8.3.2. Growth Prospects
8.4. Clinical Research Studies
8.4.1. Market Trends and Opportunities
8.4.2. Growth Prospects
9. ANIMAL SEDATIVE MARKET BY GEOGRAPHY
9.1. Introduction
9.2. North America
9.2.1. By Drug Class
9.2.2. By Animal Type
9.2.3. By Route of Administration
9.2.4. By Application
9.2.5. By Country
9.2.5.1. United States
9.2.5.1.1. Market Trends and Opportunities
9.2.5.1.2. Growth Prospects
9.2.5.2. Canada
9.2.5.2.1. Market Trends and Opportunities
9.2.5.2.2. Growth Prospects
9.2.5.3. Mexico
9.2.5.3.1. Market Trends and Opportunities
9.2.5.3.2. Growth Prospects
9.3. South America
9.3.1. By Drug Class
9.3.2. By Animal Type
9.3.3. By Route of Administration
9.3.4. By Application
9.3.5. By Country
9.3.5.1. Brazil
9.3.5.1.1. Market Trends and Opportunities
9.3.5.1.2. Growth Prospects
9.3.5.2. Argentina
9.3.5.2.1. Market Trends and Opportunities
9.3.5.2.2. Growth Prospects
9.3.5.3. Others
9.3.5.3.1. Market Trends and Opportunities
9.3.5.3.2. Growth Prospects
9.4. Europe
9.4.1. By Drug Class
9.4.2. By Animal Type
9.4.3. By Route of Administration
9.4.4. By Application
9.4.5. By Country
9.4.5.1. United Kingdom
9.4.5.1.1. Market Trends and Opportunities
9.4.5.1.2. Growth Prospects
9.4.5.2. Germany
9.4.5.2.1. Market Trends and Opportunities
9.4.5.2.2. Growth Prospects
9.4.5.3. France
9.4.5.3.1. Market Trends and Opportunities
9.4.5.3.2. Growth Prospects
9.4.5.4. Italy
9.4.5.4.1. Market Trends and Opportunities
9.4.5.4.2. Growth Prospects
9.4.5.5. Spain
9.4.5.5.1. Market Trends and Opportunities
9.4.5.5.2. Growth Prospects
9.4.5.6. Others
9.4.5.6.1. Market Trends and Opportunities
9.4.5.6.2. Growth Prospects
9.5. Middle East and Africa
9.5.1. By Drug Class
9.5.2. By Animal Type
9.5.3. By Route of Administration
9.5.4. By Application
9.5.5. By Country
9.5.5.1. Saudi Arabia
9.5.5.1.1. Market Trends and Opportunities
9.5.5.1.2. Growth Prospects
9.5.5.2. UAE
9.5.5.2.1. Market Trends and Opportunities
9.5.5.2.2. Growth Prospects
9.5.5.3. Others
9.5.5.3.1. Market Trends and Opportunities
9.5.5.3.2. Growth Prospects
9.6. Asia Pacific
9.6.1. By Drug Class
9.6.2. By Animal Type
9.6.3. By Route of Administration
9.6.4. By Application
9.6.5. By Country
9.6.5.1. Japan
9.6.5.1.1. Market Trends and Opportunities
9.6.5.1.2. Growth Prospects
9.6.5.2. China
9.6.5.2.1. Market Trends and Opportunities
9.6.5.2.2. Growth Prospects
9.6.5.3. India
9.6.5.3.1. Market Trends and Opportunities
9.6.5.3.2. Growth Prospects
9.6.5.4. South Korea
9.6.5.4.1. Market Trends and Opportunities
9.6.5.4.2. Growth Prospects
9.6.5.5. Taiwan
9.6.5.5.1. Market Trends and Opportunities
9.6.5.5.2. Growth Prospects
9.6.5.6. Thailand
9.6.5.6.1. Market Trends and Opportunities
9.6.5.6.2. Growth Prospects
9.6.5.7. Indonesia
9.6.5.7.1. Market Trends and Opportunities
9.6.5.7.2. Growth Prospects
9.6.5.8. Others
9.6.5.8.1. Market Trends and Opportunities
9.6.5.8.2. Growth Prospects
10. COMPETITIVE ENVIRONMENT AND ANALYSIS
10.1. Major Players and Strategy Analysis
10.2. Market Share Analysis
10.3. Mergers, Acquisitions, Agreements, and Collaborations
10.4. Competitive Dashboard
11. COMPANY PROFILES
11.1. Zoetis Inc.
11.2. Boehringer Ingelheim International GmbH
11.3. Merck & Co. Inc.
11.4. Elanco
11.5. Virbac Group
11.6. Dechra Pharmaceuticals PLC
11.7. Orion Corporation
11.8. Vetoquinol
11.9. Ceva